ARKG Holdings of REGN
Regeneron
Regeneron Pharmaceuticals is a biotechnology company that develops, manufactures, and commercializes innovative medicines for the treatment of serious medical conditions. It generates revenue primarily through the sales of its pharmaceutical products and partnerships with other companies in drug development and commercialization.
Trades of REGN in ARKG
The ten most recent trades of Regeneron in the ARKG ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| May 30, 2024 | Sell | $1,360,381 | 8.17% | 0.10% |
| Mar 25, 2024 | Sell | $700,826 | 3.84% | 0.04% |
| Mar 22, 2024 | Sell | $678,407 | 3.53% | 0.04% |
| Mar 21, 2024 | Sell | $1,234,560 | 6.03% | 0.08% |
| Jan 08, 2024 | Sell | $2,216,473 | 9.05% | 0.10% |
| Nov 06, 2023 | Sell | $1,608,666 | 7.04% | 0.10% |
| Sep 29, 2022 | Sell | $4,894,669 | 19.09% | 0.20% |
| Aug 29, 2022 | Sell | $306,280 | 1.11% | 0.01% |
| Aug 26, 2022 | Sell | $1,042,619 | 3.68% | 0.04% |
| Aug 25, 2022 | Sell | $83,916 | 0.29% | 0.00% |